Rituximab may obviate radiation in mediastinal B-cell lymphoma The Oncology Report Patients in a single-group, prospective phase II study were treated with dose-adjusted etoposide, doxorubicin, cyclophosphamide with vincristine, prednisone, and rituximab (DA-EPOCH-R). All but 2 of the 51 adults with lymphoma in the study were able to ... Rituxan Lymphoma Tx Works Without Radiation New Strategy Helps Young Lymphoma Patients |
